Delivery Order SPE2DR25D2005-SPE2DR26FE8D1
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,397.53 for 100 tablets of Concerta ER 36 mg on December 8, 2025, with completion expected by December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Concerta ER 36 mg tablets (100 units) with a ceiling value of $11,377.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on October 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $7,023.99. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Concerta ER 36 mg tablets (100-count bottles) valued at $6,791.05 with a firm fixed price arrangement. This non-set-aside contract represents a child delivery order executed under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $8,094.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 36 mg tablets (100-count units) valued at $10,096.03 on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $18,087.66. This firm fixed price, non-set-aside delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a direct pharmaceutical procurement to support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $3,036.82. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The order is set for ultimate completion by November 6, 2025, and will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27mg tablets, valued at $1,173.82. This firm fixed-price, non-competitive delivery order is scheduled for completion by December 12, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework. The order will be fulfilled from the company's operations in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $10,909.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by December 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8D1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,369.76 to AmerisourceBergen Drug Corp for Concerta ER 36 mg tablets (100-count units) on December 5, 2025, with a completion date of December 8, 2025. This firm fixed price, non-set-aside contract represents a small-value transaction within the pharmaceutical supply chain supporting federal medical procurement needs. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant federal contract portfolio with DLA, demonstrating its competitive capability to fulfill diverse medical supply requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 12/4/25 |